Published in

Elsevier, European Urology, 3(69), p. 505-511

DOI: 10.1016/j.eururo.2015.04.028

Links

Tools

Export citation

Search in Google Scholar

A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.

Journal article published in 2015 by Katharina Braun, Daniel D. Sjoberg, Andrew J. Vickers, Hans Lilja, Anders S. Bjartell
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

A statistical model based on four kallikrein markers (total prostate-specific antigen [tPSA], free PSA [fPSA], intact PSA, and human kallikrein-related peptidase 2) in blood can predict risk of Gleason score ≥7 (high-grade) cancer at prostate biopsy.